CHILI – Conference on Hybrid Imaging Live

Thank you to all 2,400 participants of CHILI and another 1’000 persons that watched the recording after the conference! Thank you for the interest and the support, you helped to make CHILI one of the hottest events this year!

Broadcast live from a studio in Barcelona, the Conference on Hybrid Imaging Live provided the participants with a hot mix of lectures, round table discussions and interesting clips and videos on hybrid imaging!

The conference was truly engaging: The embedded Slido tool allowed participants to ask questions in real time and was used about four hundred times during the virtual meeting.

Date: October 26, 2018

Time: 10:00-16:00 (CEST)

Location: Online

Registration fee: FREE

Registration: Closed

CME: 5 CME credits (ECMEC®s)

 

Disclaimer: CHILI and the CHILI logo are registered trademarks of the CHILI GmbH who we kindly thank for the free permission to use their trademarks.

Learning Objectives

  • to learn the principles of hybrid medical imaging
  • to learn the key clinical questions at different points in the patient’s journey
  • to understand the indications, limitations and comparative merits of each part in hybrid medical imaging in a wide range of oncologic and non-oncologic conditions, including lymphoma, lung cancer, melanoma, prostate cancer, as well as neuro-endocrine tumors
  • to appreciate the complementary roles of structural and functional/molecular imaging in cancer management
  • to understand how information derived from imaging guides patient selection for treatment and supports individualised treatment planning
  • to learn about advanced applications of hybrid imaging, such as combined PET/MRI, new radiopharmaceuticals and artificial intelligence in hybrid imaging

 

Programme

The sessions at CHILI are ascending in level, tailored to your own expertise and interests.

All sessions include 3 lectures of approx. 20 minutes and end with a round table discussion. There will be enough time to ask questions during the conference.

 

Programme overview:

10:00-11:30 – The basics of hybrid imaging

11:30-13:00 – Clinical application of hybrid imaging I

13:00-14:30 – Clinical application of hybrid imaging II

14:30-16:00 – Advanced applications in hybrid imaging

 

Session 1

The basics of hybrid imaging

10:00-11:30

10:00-10:25
The basics of hybrid imaging

Ivo Rausch

10:25-10:50
18F-FDG PET/CT in oncology with clinical case review

José L. Vercher-Conejero

10:50-11:15
PET/CT in imaging inflammation, infection and benign tumours
Jean-Noël Talbot

11:15-11:30
Round table discussion

 

Session 2

Clinical application of hybrid imaging I

11:30-13:00

11:30-11:55
PET/CT in lymphoma

Francesca Giunta

11:55-12:20
PET/CT in melanoma

Helle Westergren Hendel

12:20-12:45
18F-FDG PET/CT in oncology: Pitfalls with clinical case review

Christina Pfannenberg

12:45-13:00
Round table discussion

 

 

Session 3

Clinical application of hybrid imaging II

13:00-14:30

13:00-13:25
PET/CT in neuro-endocrine tumors

Jann Mortensen

13:25-13:50
The role of PSMA hybrid imaging in the clinical management of prostate cancer
Clemens Cyran

13:50-14:15
Theragnostics: hybrid imaging and radionuclide therapy

Harun Ilhan

14:15-14:30
Round table discussion

 

Session 4

Advanced applications in hybrid imaging

14:30-16:00

14:30-14:55
Combined PET/MRI: Methods & applications

Thomas Beyer

14:55-15:20
Far beyond FDG: future targets for new radiopharmaceuticals in hybrid imaging?

Harun Ilhan

15:20-15:45
Artificial intelligence in hybrid imaging – the best of all worlds?

Irène Buvat

15:45-16:00
Round table discussion

 

Preliminary Programme

The sessions at CHILI are ascending in level, tailored to your own expertise and interests.

All sessions include 3 lectures of approx. 20 minutes and end with a round table discussion. There will be enough time to ask questions during the conference.

The programme is subject to change.

Session 1

The basics of hybrid imaging

10:00-11:30

10:00-10:25
The basics of hybrid imaging

Ivo Rausch

10:25-10:50
18F-FDG PET/CT in oncology with clinical case review

José L. Vercher-Conejero

10:50-11:15
PET/CT in imaging inflammation, infection and benign tumours
Jean-Noël Talbot

11:15-11:30
Round table discussion

 

Session 2

Clinical application of hybrid imaging I

11:30-13:00

11:30-11:55
PET/CT in lymphoma

Francesca Giunta

11:55-12:20
PET/CT in melanoma

Helle Westergren Hendel

12:20-12:45
18F-FDG PET/CT in oncology: Pitfalls with clinical case review

Christina Pfannenberg

12:45-13:00
Round table discussion

 

 

Session 3

Clinical application of hybrid imaging II

13:00-14:30

13:00-13:25
PET/CT in neuro-endocrine tumors

Jann Mortensen

13:25-13:50
The role of PSMA hybrid imaging in the clinical management of prostate cancer
Clemens Cyran

13:50-14:15
Theragnostics: hybrid imaging and radionuclide therapy

Harun Ilhan

14:15-14:30
Round table discussion

 

Session 4

Advanced applications in hybrid imaging

14:30-16:00

14:30-14:55
Combined PET/MRI: Methods & applications

Thomas Beyer

14:55-15:20
Far beyond FDG: future targets for new radiopharmaceuticals in hybrid imaging?

Harun Ilhan

15:20-15:45
Artificial intelligence in hybrid imaging – the best of all worlds?

Irène Buvat

15:45-16:00
Round table discussion